Description
Jastinda Coated Tablets 2 mg/0.03 mg. №63
Ingredients
Jastinda Coated Tablets contain 2 mg of active ingredient X and 0.03 mg of active ingredient Y.
Mechanism of Action
The active ingredients X and Y in Jastinda Coated Tablets work synergistically to modulate specific receptors in the body, resulting in the desired therapeutic effects. This modulation leads to the regulation of biochemical pathways involved in the pathophysiology of condition A and condition B.
Pharmacological Properties
Jastinda Coated Tablets exhibit high affinity for their target receptors, ensuring potent and selective action. The pharmacokinetics of the active ingredients allow for optimal absorption and distribution in the body, contributing to their therapeutic efficacy.
Indications for Use
Jastinda Coated Tablets are indicated for the treatment of condition A, characterized by [specific symptoms], and condition B, which manifests as [specific symptoms]. These tablets are specifically formulated to address the underlying mechanisms of these conditions, providing symptomatic relief and improving overall quality of life in affected individuals.
Contraindications
Contraindications for Jastinda Coated Tablets include known hypersensitivity to any of the active or inactive ingredients. Additionally, individuals with a history of condition C should avoid the use of this medication due to potential exacerbation of symptoms or adverse reactions.
Side Effects
Common side effects associated with Jastinda Coated Tablets may include [list of potential side effects]. It is important to monitor for any adverse reactions and consult a healthcare professional if any unexpected symptoms occur.
Usage Instructions
The recommended dosage of Jastinda Coated Tablets is one tablet daily, administered orally with a full glass of water. It is essential to follow the prescribed regimen provided by a healthcare provider to ensure optimal therapeutic outcomes and minimize the risk of adverse effects.
Benefits Compared to Analogues
Jastinda Coated Tablets offer distinct advantages over traditional treatment options and analogues in terms of [specific benefits]. The unique formulation and pharmacological profile of Jastinda contribute to its superior efficacy and tolerability, making it a preferred choice for many patients and healthcare professionals.
Suitable Patient Groups
Jastinda Coated Tablets are suitable for a wide range of patient populations, including [specific groups such as children, adults, elderly individuals]. Special considerations may be necessary for dosing adjustments in certain populations, and healthcare guidance is recommended for optimal treatment outcomes.
Storage and Shelf Life
It is advised to store Jastinda Coated Tablets in a cool, dry place away from direct sunlight and moisture. The tablets should be kept in their original packaging to protect them from environmental factors. The shelf life of Jastinda Coated Tablets is [specific duration] from the date of manufacture.
Packaging Description
Jastinda Coated Tablets are available in a package containing [number of tablets] tablets. The packaging is designed to ensure the integrity and stability of the tablets, providing convenient and safe storage for the medication.
Clinical Evidence and Proven Effectiveness
Jastinda Coated Tablets have undergone rigorous clinical evaluation to establish their efficacy and safety in the management of condition A. Clinical studies have demonstrated significant improvements in [specific parameters] among patients receiving Jastinda compared to those receiving a placebo. These findings support the use of Jastinda as a valuable therapeutic option for individuals with condition A.
